These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9719627)

  • 1. Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents.
    Nayak S; Lee PA; Witchel SF
    Mol Genet Metab; 1998 Jul; 64(3):184-92. PubMed ID: 9719627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
    Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid resistance in premature pubarche and adolescent hyperandrogenism.
    Witchel SF; Smith RR
    Mol Genet Metab; 1999 Feb; 66(2):137-41. PubMed ID: 10068517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
    Simard J; Moisan AM; Morel Y
    Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
    Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess.
    Moran C; Potter HD; Reyna R; Boots LR; Azziz R
    Am J Obstet Gynecol; 1999 Sep; 181(3):596-600. PubMed ID: 10486469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the melanocortin-4 receptor (MC4R) gene in children with premature pubarche and adolescent girls with hyperandrogenism.
    Roldan Martin MB; White C; Kammerer C; Witchel SF
    Fertil Steril; 2004 Nov; 82(5):1460-2. PubMed ID: 15533382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H; Zhang L; Yang X; Chang YT; Kappy M; Slover RS; Jorgensen V; Pang S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homozygous nonsense mutations E135* in the type II 3beta-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online.
    Marui S; Torrealba IM; Russell AJ; Latronico AC; Sutcliffe RG; Mendonca BB
    Hum Mutat; 1998; 12(2):139. PubMed ID: 10694926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Johannsen TH; Mallet D; Dige-Petersen H; Müller J; Main KM; Morel Y; Forest MG
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2076-80. PubMed ID: 15671104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women.
    Blanché H; Vexiau P; Clauin S; Le Gall I; Fiet J; Mornet E; Dausset J; Bellanné-Chantelot C
    Hum Genet; 1997 Nov; 101(1):56-60. PubMed ID: 9385370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.
    Witchel SF; Lee PA; Suda-Hartman M; Hoffman EP
    Biochem Mol Med; 1997 Dec; 62(2):151-8. PubMed ID: 9441866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
    Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Rhéaume E; Simard J; Morel Y; Mebarki F; Zachmann M; Forest MG; New MI; Labrie F
    Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.
    Moran C; Azziz R; Carmina E; Dewailly D; Fruzzetti F; Ibañez L; Knochenhauer ES; Marcondes JA; Mendonca BB; Pignatelli D; Pugeat M; Rohmer V; Speiser PW; Witchel SF
    Am J Obstet Gynecol; 2000 Dec; 183(6):1468-74. PubMed ID: 11120512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
    Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism.
    Witchel SF; Smith R; Tomboc M; Aston CE
    Fertil Steril; 2001 Apr; 75(4):724-30. PubMed ID: 11287026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.